Home › Compare › TLKMF vs ABBV
TLKMF yields 8.19% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 2
Combined, TLKMF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TLKMF + ABBV for your $10,000?
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk provides telecommunications, informatics, and network services worldwide. The company's Mobile segment offers mobile voice, SMS, and mobile broadband services; and digital services, including financial services, video on demand, music, gaming, IoT, big data analytics, and digital advertising services. Its Consumer segment provides fixed voice and broadband services; and IPTV and related consumer digital services. The company's Enterprise segment offers ICT and digital platform that covers enterprise-grade connectivity services, including satellite, IT services, data center and cloud, and business process outsourcing services, as well as CPE trading and managed, cyber security, financial, big data, digital advertising, e-health, managed ATM, and professional services. Its Wholesale and International Business segment provides wholesale voice, managed, A2P SMS, IP transit and connectivity, data center and cloud, security, and value added and digital services; mobile network operator, mobile virtual network operator, and call center services; and tower and infrastructure services to other licensed operator companies and institutions. The company's Others segment offers digital services, such as digital platform, digital content, and e-commerce; and property management services. The company also provides building management and maintenance services, payment, business management consulting and capital venture, health insurance administration, tourism, directory information, telecommunication construction, and multimedia portal services; acts as a civil consultant and developer; and leases offices. As of December 31, 2020, it had approximately 9.1 million fixed wireline subscribers, including 8.0 million fixed broadband subscribers; and 169.5 million cellular subscribers, including 115.9 million mobile broadband subscribers. The company was founded in 1884 and is headquartered in Bandung, Indonesia.
Full TLKMF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.